You have 9 free searches left this month | for more free features.

Drug

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pattern of Acute Antipsychotic Drug- Toxicity in Children

Not yet recruiting
  • Antipsychotic Drug- Toxicity
    • (no location specified)
    Nov 6, 2023

    Opioid Use Disorder, Opioid Dependence Trial in Baltimore (Drug A (Blinded Drug), Drug B (Blinded Drug), Drug C (Blinded Drug))

    Not yet recruiting
    • Opioid Use Disorder
    • Opioid Dependence
    • Drug A (Blinded Drug)
    • +5 more
    • Baltimore, Maryland
      Behavioral Pharmacology Research Unit
    Apr 25, 2023

    Drug Drug Interaction Trial (Midazolam, Omeprazole, Rosuvastatin)

    Not yet recruiting
    • Drug Drug Interaction
    • (no location specified)
    Sep 4, 2023

    Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole

    Completed
    • Drug-drug Interaction Study
    • SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
    • Hyderabad, India
      QPS Bioserve India Pvt Limited
    Nov 20, 2023

    Coronary Heart Disease, Angioplasty, Balloon Trial in Xi'an (Drug-coated balloon, Drug-eluting stents)

    Active, not recruiting
    • Coronary Heart Disease
    • Angioplasty, Balloon
    • Drug-coated balloon
    • Drug-eluting stents
    • Xi'an, Shannxi, China
      Ling Tao
    Jun 29, 2023

    Diabetes in Adults Trial in Shanghai (Hydrochlorothiazide?Henagliflozin Proline)

    Completed
    • Diabetes in Adults
    • Hydrochlorothiazide、Henagliflozin Proline
    • Shanghai, Shanghai, China
      Shanghai Xuhui Central Hospital
    Oct 12, 2023

    Healthy, Drug-Drug Interaction Trial in Shanghai (JMKX000623, Metformin)

    Active, not recruiting
    • Healthy
    • Drug-Drug Interaction
    • Shanghai, Shanghai, China
      Huashan Hospital Fudan University
    Sep 30, 2023

    Drug Drug Interaction Trial in Guangzhou (Digoxin, Rosuvastatin, ZSP1273)

    Recruiting
    • Drug Drug Interaction
    • Guangzhou, China
      The First Affiliated Hospital of Guangzhou University of Chinese
    Jul 13, 2023

    Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis Trial in Beijing (Drug-coated balloon (Bingo© [Paclitaxel-coated

    Recruiting
    • Drug-coated Balloon
    • +2 more
    • Drug-coated balloon (Bingo© [Paclitaxel-coated Balloon], Yinyi Ltd., China)
    • Drug-eluting stent
    • Beijing, China
      Fuwai Hospital, National Center for Cardiovascular Diseases,Chin
    Oct 14, 2023

    Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)

    Enrolling by invitation
    • Drug Interactions
    • Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Oct 25, 2023

    Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

    Not yet recruiting
    • Myelofibrosis
    • TQ05105 tablets
    • +2 more
    • Jinan, Shandong, China
      Shandong Provincial Hospital
    Aug 30, 2023

    Healthy Volunteer Trial in Grayslake (ABBV-903, Midazolam)

    Not yet recruiting
    • Healthy Volunteer
    • Grayslake, Illinois
      Acpru /Id# 254970
    May 31, 2023

    Substance Use Disorder, Cocaine Use Disorder Trial in New York (Methylphenidate, Memory reconsolidation, Placebo)

    Recruiting
    • Substance Use Disorder
    • Cocaine Use Disorder
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jul 28, 2023

    Healthy Participants Trial in Cypress, Miami, Las Vegas (Abatacept)

    Not yet recruiting
    • Healthy Participants
    • Abatacept
    • Cypress, California
    • +2 more
    Aug 1, 2023

    Drug-Induced Nephropathy Trial in Cairo (N Acetylcysteine)

    Recruiting
    • Drug-Induced Nephropathy
    • N Acetylcysteine
    • Cairo, Egypt
      Helwan University
    Nov 7, 2023

    Drug Drug Interaction Trial in Seoul (DWC202313, DWC202314)

    Recruiting
    • Drug Drug Interaction
    • Seoul, Korea, Republic of
      H Plus YANGJI Hospital
    Nov 5, 2023

    Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)

    Completed
    • Healthy Participant
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Oct 11, 2023

    Stroke Sequelae, Stroke Trial in Anyang-si (NDC-002)

    Completed
    • Stroke Sequelae
    • Stroke
    • Anyang-si, Korea, Republic of
      Insan Medical Foundation Metro Hospital
    Oct 22, 2023

    Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)

    Recruiting
    • Drug-eluting Stent
    • Coronary Artery Disease
    • Genoss® DES system, Genoss® Osfit system
    • Suwon, Korea, Republic of
      Ajou University Hospital
    Sep 27, 2023

    NSCLC Trial (HLX208, Itraconazole 200 mg, Rifampicin)

    Not yet recruiting
    • NSCLC
    • (no location specified)
    Jun 5, 2023

    Alleged Drug Allergies in Military General Medicine: Patients'

    Recruiting
    • Allergy Penicillin
    • Interview
    • Versailles, France
      15ème antenne médicale - Camp des Matelots
    Oct 31, 2023

    Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)

    Completed
    • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
    • Tempe, Arizona
      Celerion
    Aug 15, 2023

    Addiction, Opioid Use, Substance Use Disorders Trial (Placebo, Auvelity)

    Not yet recruiting
    • Addiction
    • +3 more
    • (no location specified)
    Aug 3, 2023

    Healthy Volunteer Study Trial in Québec (Cohort 1 BEM + Ruzasvir, Cohort 2 Ruzasvir + BEM)

    Recruiting
    • Healthy Volunteer Study
    • Cohort 1 BEM + Ruzasvir
    • Cohort 2 Ruzasvir + BEM
    • Québec, Montreal, Quebec, Canada
      Atea Study Site
    Feb 9, 2023

    Drug Resistant Epilepsy Trial in Medan (Cholecalciferol, )

    Not yet recruiting
    • Drug Resistant Epilepsy
    • Medan, North Sumatra, Indonesia
      Faculty of Medicine Universitas Sumatera Utara
    Sep 21, 2023